Rang	Name	Position
1	Mr. Mark L. Baum J.D.	CEO, Chairman of the Board & Founder
2	Mr. Andrew R. Boll C.F.A., C.M.A.	President, CFO & Chief Accounting Officer
3	Dr. Amir W. Shojaei Ph.D., Pharm.D.	Chief Scientific Officer
4	Mr. Francis W. Mullery	President & CEO of Harrow's ImprimisRx Division
5	Mr. Michael D. Biega	Vice President of Investor Relations & Communications
6	Mr. Brett A. Burrell	Vice President of Legal & Compliance
7	Ms. Kim Barratt	Chief Talent Officer
8	Dr. Mark A. Mannebach Ph.D., R.Ph.	Head of Regulatory Affairs & Pharmacovigilance
9	Dr. Prashanth S. Annavajjhala	Chief of Staff
10	Mr. Patrick W. Sullivan	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	7,31%	0,08 Mrd. USD
2	Opaleye Management Inc	6,40%	0,07 Mrd. USD
3	Private Capital Management, LLC	4,26%	0,05 Mrd. USD
4	Vanguard Capital Management, LLC	3,78%	0,04 Mrd. USD
5	Deep Track Capital, LP	2,58%	0,03 Mrd. USD
6	State Street Corp	2,51%	0,03 Mrd. USD
7	Geode Capital Management, LLC	2,42%	0,03 Mrd. USD
8	BAMCO Inc	2,16%	0,02 Mrd. USD
9	Dimensional Fund Advisors, Inc.	1,78%	0,02 Mrd. USD
10	Jupiter Topco LLC	1,54%	0,02 Mrd. USD
11	Divisadero Street Capital Management, LP	1,17%	0,01 Mrd. USD
12	Rice Hall James & Associates, LLC	1,03%	0,01 Mrd. USD
13	Marshall Wace Asset Management Ltd	0,99%	0,01 Mrd. USD
14	Citadel Advisors Llc	0,96%	0,01 Mrd. USD
15	Northern Trust Corp	0,86%	0,01 Mrd. USD
16	Schonfeld Strategic Advisors LLC	0,85%	0,01 Mrd. USD
17	Vanguard Portfolio Management, LLC	0,85%	0,01 Mrd. USD
18	Charles Schwab Investment Management Inc	0,73%	0,01 Mrd. USD
19	Vanguard Fiduciary Trust Co	0,63%	0,01 Mrd. USD
20	Westside Investment Management, Inc.	0,60%	0,01 Mrd. USD